Abstract
Objective To characterize the clinical course of delirium for COVID-19 patients in the intensive care unit, including post-discharge cognitive outcomes.
Patients and Methods A retrospective chart review was conducted for patients diagnosed with COVID-19 (n=148) admitted to an intensive care unit at Michigan Medicine between March 1, 2020 and May 31, 2020. A validated chart review method was used to identify presence of delirium, and various measures (e.g., Family Confusion Assessment Method, Short Blessed Test, Patient-Health Questionnaire-9) were used to determine neuropsychological outcomes between 1-2 months after hospital discharge.
Results Delirium was identified in 108/148 (73%) patients in the study cohort, with median (interquartile range) duration lasting 10 (4 – 17) days. In the delirium cohort, 50% (54/108) of patients were African American, and delirious patients were more likely to be female (76/108, 70%) (absolute standardized differences >.30). Sedation regimens, inflammation, deviation from delirium prevention protocols, and hypoxic-ischemic injury were likely contributing factors, and the most common disposition for delirious patients was a skilled care facility (41/108, 38%). Among patients who were delirious during hospitalization, 4/17 (24%) later screened positive for delirium at home based on caretaker assessment, 5/22 (23%) demonstrated signs of questionable cognitive impairment or cognitive impairment consistent with dementia, and 3/25 (12%) screened positive for depression within two months after discharge.
Conclusion Patients with COVID-19 commonly experience a prolonged course of delirium in the intensive care unit, likely with multiple contributing factors. Furthermore, neuropsychological impairment may persist after discharge.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Supported by the Department of Anesthesiology, University of Michigan Medical School.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval was obtained from the University of Michigan Medical School Institutional Review Board (HUM00182646). *Pertaining to question #3, re: patient/participant consent: as this was a retrospective chart review, *no patient/participant consent was required per IRB oversight.*
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Financial support and conflict of interest disclosures: Supported by the Department of Anesthesiology, University of Michigan Medical School. The funding source had no role in study design, operations, or analysis. The authors report no conflicts of interest to disclose
Delirium data have been updated based on additional chart review. ICU bundle implementation data have also been updated, in a targeted manner, to provide the occurrence/compliance rate for bundle activities (based on data available). Lastly, absolute standardized differences have been included to determine differences in baseline characteristics between delirious and non-delirious groups.
Data Availability
All de-identified data will be made available upon request.
Abbreviations and Acronyms
- ABCDEF
- Assess, prevent and manage pain; both spontaneous awakening and breathing trials; choice of analgesia and sedation; delirium: assess, prevent, and manage; early mobility and exercise; family engagement and empowerment
- COVID-19
- coronavirus disease 2019
- FAM-CAM
- family confusion assessment method
- FLAIR
- fluid attenuated inversion recovery
- ICU
- intensive care unit
- MRI
- magnetic resonance imaging
- PROMIS
- patient-reported outcomes measurement information system
- SARS-CoV-2
- severe acute respiratory syndrome coronavirus 2
- SWI
- susceptibility weighted imaging
